Literature DB >> 22121920

Soluble Aβ oligomer production and toxicity.

Megan E Larson1,2,3, Sylvain E Lesné1,2,3.   

Abstract

For nearly 100 years following the first description of this neurological disorder by Dr Alois Alzheimer, amyloid plaques and neurofibrillary tangles have been hypothesized to cause neuronal loss. With evidence that the extent of insoluble, deposited amyloid poorly correlated with cognitive impairment, research efforts focused on soluble forms of Aβ, also referred as Aβ oligomers. Following a decade of studies, soluble oligomeric forms of Aβ are now believed to induce the deleterious cascade(s) involved in the pathophysiology of Alzheimer's disease. In this review, we will discuss our current understanding about endogenous oligomeric Aβ production, their relative toxicity in vivo and in vitro, and explore the potential future directions needed for the field.
© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22121920      PMCID: PMC3254782          DOI: 10.1111/j.1471-4159.2011.07478.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  160 in total

1.  Role of Species-Specific Primary Structure Differences in Aβ42 Assembly and Neurotoxicity.

Authors:  Robin Roychaudhuri; Xueyun Zheng; Aleksey Lomakin; Panchanan Maiti; Margaret M Condron; George B Benedek; Gal Bitan; Michael T Bowers; David B Teplow
Journal:  ACS Chem Neurosci       Date:  2015-10-19       Impact factor: 4.418

Review 2.  The Essential Role of Soluble Aβ Oligomers in Alzheimer's Disease.

Authors:  Zi-Xuan Wang; Lan Tan; Jinyuan Liu; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2015-04-02       Impact factor: 5.590

3.  Alzheimer's amyloid-β oligomers rescue cellular prion protein induced tau reduction via the Fyn pathway.

Authors:  Rong-Jie Chen; Wei-Wei Chang; Yu-Chun Lin; Pei-Lin Cheng; Yun-Ru Chen
Journal:  ACS Chem Neurosci       Date:  2013-07-18       Impact factor: 4.418

4.  Effect of α-synuclein on amyloid β-induced toxicity: relevance to Lewy body variant of Alzheimer disease.

Authors:  Rosa Resende; Sueli C F Marques; Elisabete Ferreiro; Isaura Simões; Catarina R Oliveira; Cláudia M F Pereira
Journal:  Neurochem Res       Date:  2013-02-07       Impact factor: 3.996

5.  Pharmacokinetic Properties of a Novel D-Peptide Developed to be Therapeutically Active Against Toxic β-Amyloid Oligomers.

Authors:  Leonie H E Leithold; Nan Jiang; Julia Post; Tamar Ziehm; Elena Schartmann; Janine Kutzsche; N Jon Shah; Jörg Breitkreutz; Karl-Josef Langen; Antje Willuweit; Dieter Willbold
Journal:  Pharm Res       Date:  2015-09-17       Impact factor: 4.200

6.  Structures and dynamics of β-barrel oligomer intermediates of amyloid-beta16-22 aggregation.

Authors:  Xinwei Ge; Yunxiang Sun; Feng Ding
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-03-14       Impact factor: 3.747

Review 7.  Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer's Disease Immunotherapy.

Authors:  Jing Liu; Bin Yang; Jun Ke; Wenjia Li; Wen-Chen Suen
Journal:  Drugs Aging       Date:  2016-10       Impact factor: 3.923

8.  Taxifolin prevents β-amyloid-induced impairments of synaptic formation and deficits of memory via the inhibition of cytosolic phospholipase A2/prostaglandin E2 content.

Authors:  Yuanyuan Wang; Qinwen Wang; Xiaoming Bao; Yanfei Ding; Jieyi Shentu; Wei Cui; Xiaowei Chen; Xiaofei Wei; Shujun Xu
Journal:  Metab Brain Dis       Date:  2018-03-14       Impact factor: 3.584

Review 9.  Cellular membrane fluidity in amyloid precursor protein processing.

Authors:  Xiaoguang Yang; Grace Y Sun; Gunter P Eckert; James C-M Lee
Journal:  Mol Neurobiol       Date:  2014-02-20       Impact factor: 5.590

10.  Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.

Authors:  Mathew A Sherman; Michael LaCroix; Fatou Amar; Megan E Larson; Colleen Forster; Adriano Aguzzi; David A Bennett; Martin Ramsden; Sylvain E Lesné
Journal:  J Neurosci       Date:  2016-09-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.